<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        24-762-12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2012
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE 5% SOD CHL. 0.2% I.V. INFU. IN VIAFLEX
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEXTROSE,SODIUM CHLORIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5,0.2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        %
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Intravenous infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bag
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        5.30
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="BAXTER CO LIMITED" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 613]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            BAXTER CO LIMITED
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Baxter Company Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        B05XA30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dextrose 5 % and Sodium Chloride 0.2%Infusion is a solution of the following substances in water:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sugar (Dextrose)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sodium chloride (salt).</p><p>Dextrose is one of the body&rsquo;s sources of energy. This solution for infusion provides 200 kilocalories per litre.</p><p>Sodium and chloride are chemical substances found in the blood.</p><p>Dextrose 5 % and Sodium Chloride 0.2%Infusion is used:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; as a source of carbohydrate (sugar).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to treat a loss of body water (dehydration) and chemicals (e.g. by heavy sweating, kidney disorders)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to treat you, if the volume of blood in your blood vessels is low (hypovolaemia).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do</strong><strong> NOT receive Dextrose 5 % and Sodium Chloride 0.2%Infusion if you are suffering from any of the following conditions</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when you know you are allergic to the product</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when there is too much fluid in the spaces around the cells of the body (extracellular hyperhydration)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; when there is a larger volume of blood in the blood vessels than there should be (hypervolaemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; more fluid and sodium than normal in the body (fluid and sodium retention)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; severe kidney problems that mean you produce less urine than usual or none at all (oliguria or anuria)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; uncompensated heart failure. This is heart failure that is not adequately treated and causes symptoms such as:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shortness of breath</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; swelling of the ankles.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lower levels of sodium in the blood than normal (hyponatraemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lower levels of chloride in the blood than normal (hypochloraemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; build up of fluid under the skin, affecting all parts of the body (general oedema)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; diabetes that is not adequately treated, allowing your blood sugar levels to rise above normal (uncompensated diabetes)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; other states of dextrose intolerance, for example:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metabolic stress (when the body&rsquo;s metabolism does not function correctly, e.g. due to severe illness)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hyperosmolar coma (unconsciousness). This is a type of coma that can occur if you have diabetes and do not receive enough medicine.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a very high amount of sugar in the blood (significant hyperglycaemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; higher levels of lactate in the blood than normal (hyperlactataemia)</p><p>Warnings and precautions</p><p>Please tell your doctor if you have or have had any of the following medical conditions.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; conditions associated with sodium retention, fluid overload and oedema, such as</p><p>-&nbsp;&nbsp;&nbsp; aldosteronism (a disease that causes high levels of a hormone called aldosterone) associated with</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure (hypertension)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; heart failure</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; poor liver function or liver disease that causes fluid to build up within the abdomen (ascitic cirrhosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; poor kidney function</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure during pregnancy (pre-eclampsia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; taking certain medications, See below, &ldquo;other medicines and Dextrose 5 % and Sodium Chloride 0.2%5 Infusion&rdquo;).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a disorder in which the blood becomes too alkaline (metabolic alkalosis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; muscle weakness and periodic paralysis due to low thyroid activity (thyrotoxic periodic paralysis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; rapid loss of water from the body e.g. due to vomiting or diarrhoea</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; being on a low potassium diet for a long time</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; allergy, in particular to corn (Dextrose 5 % and Sodium Chloride 0.2%Infusion contains sugar derived from corn)</p><p>The infusion may cause</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lower levels of sodium in the blood than normal (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death. Acute hyponatraemic encephalopathy is a serious complication. Some patients are at higher risk for hyponatraemia. In general this applies to</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; young and old people,</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; women and</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; anyone with a condition such as low levels of oxygen in your blood (hypoxemia), drinking a lot due to a dry mouth (psychogenic polydipsia).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have recently been operated.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in the concentrations of the chemicals in the blood (electrolyte disturbances)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a build up of fluid under the skin, affecting all parts of the body (general oedema), around the ankles (peripheral oedema) or in the lungs (pulmonary oedema)</p><p>When you are given this infusion, your doctor will take blood and urine samples to monitor:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the amount of chemicals such as sodium and chloride in your blood (your plasma electrolytes)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the amount of sugar (dextrose)</p><p>As Dextrose 5 % and Sodium Chloride 0.2% Infusion contains sugar (dextrose), it can cause a high level of sugar in the blood (hyperglycaemia). If this occurs, your doctor may:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; adjust the speed of infusion</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; give you insulin to reduce the blood sugar levels This is particularly important:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are diabetic</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; if you have not been eating well or have been drinking too much alcohol for a long time</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have recently had a stroke (acute ischaemic stroke). High levels of sugar in the blood can worsen the effects of stoke and affect recovery</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have had head injury within the past 24 hours</p><p>Your doctor will take into account if you are receiving parenteral nutrition (nutrition given by infusion into a vein). During long-term treatment with Dextrose&nbsp; 5% and Sodium Chloride 0.2% Infusion, you may need to be given extra nutrition. Your doctor should also monitor the level of potassium in your blood to avoid this becoming lower than normal (hypokalaemia).</p><p>Children</p><p>Special care should be taken when giving this solution to children, infants, and newborns (especially premature babies and those with low birth weight). Children, infants and newborns may not have a good ability to handle the chemicals in the solution.</p><p>Younger children are at an increased risk of developing levels of sugar in the blood that are either too high or too low, and therefore need close monitoring during treatment to ensure that sugar levels are controlled. Low sugar levels in the newborn can cause prolonged seizures, coma and brain damage. High sugar levels have been associated with bleeding into the brain, bacterial and fungal infection, damage to the eye (retinopathy of prematurity), infections in the intestinal tract, lung problems, prolonged length of hospital stay and death.</p><p>Children are at higher risk for having or developing a too low sodium concentration in their blood (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death. Acute hyponatraemic encephalopathy is a serious complication, especially in children.</p><p>Your doctor knows this and will closely monitor the amount of chemicals such as glucose (sugar), sodium and chloride in your child&rsquo;s blood (plasma electrolytes)</p><p>Other medicines and Dextrose 5 % and Sodium Chloride 0.2%Infusion</p><p>Tell your doctor or nurse if you are taking or have recently taken any other medicines.</p><p>It is particularly important that you inform your doctor if you are taking:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; corticosteroids (anti-inflammatory medicines)</p><p>These medicines can cause the body to accumulate sodium and water, leading to:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; tissue swelling due to fluid collection under the skin (oedema)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high blood pressure (hypertension).</p><p>Other medicines that can affect or be affected Dextrose 5 % and Sodium Chloride 0.2% Infusion:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; lithium (used to treat psychiatric illnesses)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; insulin (used to treat diabetes)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; water tablets (diuretics)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; beta blockers (heart tablets)</p><p>Dextrose 5 % and Sodium Chloride 0.2% Infusion with food, drink and alcohol</p><p>You should ask your doctor about what you can eat or drink.</p><p>Pregnancy, breast-feeding and fertility</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.</p><p>Dextrose 5 % and Sodium Chloride 0.2% Infusion can be used during breastfeeding.</p><p>if another medicine is to be added to your solution for infusion during pregnancy or breast-feeding you should:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; consult your doctor</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; read the Patient Leaflet of the medicine that is to be added.</p><p>Driving and using machines</p><p>Dextrose 5 % and Sodium Chloride 0.2% Infusion does not affect your ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will be given Dextrose 5 % and Sodium Chloride 0.2% Infusion by a doctor or nurse. Your doctor will decide on how much you need and when it is to be given. This will depend on your age, weight, condition and the reason for treatment. The amount you are given may also be affected by other treatments you are receiving.</p><p>You should NOT be given Dextrose 5 % and Sodium Chloride 0.2% Infusion if there are particles floating in the solution or if the pack is damaged in any way.</p><p><strong>&nbsp;</strong>Dextrose 5 % and Sodium Chloride 0.2%Infusion will usually be given to you through a plastic tube attached to a needle in a vein. Usually a vein in your arm is used to give you the infusion. However, your doctor may use another method to give you the medicine.</p><p>Any unused solution should be thrown away. You should NOT be given an infusion of Dextrose 5 % and Sodium Chloride 0.2% Infusion from a bag that has been partly used.</p><p>If you receive more Dextrose 5 % and Sodium Chloride 0.2% Infusion than you should</p><p>If you are given too much Dextrose 5 % and Sodium Chloride 0.2%Infusion (over-infusion) or if it is given too fast, this may lead to the following symptoms:</p><p>high levels of sugar in the blood (hyperglycemia) Symptoms include:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; dry mouth due to lack of water in body tissues (dehydration)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; thirst</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fatigue</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; frequent urination due to increased urine production (osmotic diuresis)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blurred vision</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fatigue</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low levels of sodium in the blood (hyponatraemia). Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, swelling of the brain (cerebral oedema) and death</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; build-up of fluid in the body causing swelling (oedema).</p><p>If you develop any of these symptoms you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment depending on the symptoms.</p><p>If a medicine has been added to your Dextrose 5 % and Sodium Chloride 0.2% Infusion before over- infusion occurs, that medicine may also cause symptoms. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p>Stop receiving your Dextrose 5 % and Sodium Chloride 0.2%Infusion</p><p><strong>&nbsp;</strong>Your doctor will decide when to stop giving you this infusion.</p><p>If you have any further questions on the use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them</p><p>The side effects can be related to Dextrose 5 % and Sodium Chloride 0.2% Infusion itself. This includes:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp; hypersensitivity reactions, including a serious allergic reaction called anaphylaxis (potential manifestation in patients with allergy to corn)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; high level of sugar in the blood (hyperglycaemia)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; low levels of sodium in the blood (hyponatraemia)</p><p>The side effects can be related to the administration technique. This includes:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; fever (febrile response)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; chills</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; itching (pruritus) or rash</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; local pain or reaction (pain or vesicles at the site of infusion)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; irritation and inflammation of the vein into which the solution is infused (phlebitis). This can cause redness, pain , swelling or vesicles along the path of the vein into which the solution is infused.</p><p>If a medicine has been added to the solution for infusion, the added medicine may also cause side effects. These side effects will depend on the medicine that has been added. You should read the Package Leaflet of the added medicine for a list of possible symptoms.</p><p><u>Reporting of side effects</u></p><p>If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. If any side effects occur, the infusion must be stopped.</p><p>You can also report side effects directly (see details below). By reporting side affects you can help provide more information on the safety of this medicine.</p><table cellspacing="0" cellpadding="0" border="1" style="width:763px"><tbody><tr><td style="vertical-align:top; width:761px"><p><strong><em>Saudi Arabia:</em></strong></p><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>- Fax: +966-11-205-7662</p><p>- Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>- Toll free phone: 8002490000</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: www.sfda.gov.sa/npc</p><p><strong><em>Other GCC States:</em></strong></p><p>- Please contact the relevant competent authority.<strong><em>&nbsp;</em></strong></p><p>&nbsp;</p></td></tr></tbody></table><p><br /><!--[if mso & !supportInlineShapes & supportFields]><span
style='font-size:10.0pt;font-family:"Times New Roman",serif;mso-fareast-font-family:
"Times New Roman"'><v:shape id="_x0000_i1027" type="#_x0000_t75" style='width:466.1pt;
 height:27.5pt'>
 <v:imagedata croptop="-65520f" cropbottom="65520f"/>
</v:shape><span style='mso-element:field-end'></span></span><![endif]--></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Dextrose 5 % and Sodium Chloride 0.2% Infusion Do not store above 30&deg;C.</p><p>Dextrose 5 % and Sodium Chloride 0.2%Infusion should NOT be given to you after the expiry date which is stated on the bag after EXP. The expiry date refers to the last day of that month.</p><p>You should not be given Dextrose 5 % and Sodium Chloride 0.2%Infusion, if there are particles floating in the solution or if the unit is damaged in any way.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substances are:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sugar (dextrose): 50 g per litre</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sodium chloride: 2 g per litre</p><p>The ingredients are water for injections, hydrochloric acid and Sodium hydroxide</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Dextrose 5 % and Sodium Chloride 0.2%Solution for Infusion looks like and contents of the pack

The bags known as VIAFLEX are composed of poly (vinyl chloride) plastic bag are (VIAFLEX). Each bag is wrapped in a sealed, protective, outer plastic overpouch
.
-	The bag size is
-	40 bags of 250 ml
-	26 bags of 500 ml
-	16 bags of 1000 ml
 
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder:</p><p>Baxter Company Limited</p><p>2nd Industrial Zone Road no 2041 Dammam, Saudi Arabia</p><p>Manufacturers:</p><p>Baxter Company Limited</p><p>2nd Industrial Zone Road no 2041 Dammam, Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                03/2016
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">دكستروز 5% وكلوريد الصوديوم 0.2% هو محلول يضمّ المواد التالية في الماء:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكر (دكستروز)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كلوريد الصوديوم (الملح).</p><p dir="RTL">الدكستروز هو أحد مصادر الطاقة في الجسم. يوفّر محلول الحقن هذا 200 كيلو كالوري في الليتر الواحد.</p><p dir="RTL">الصوديوم والكلوريد هما مادّتان كيميائيّتان موجودتان في الدم.</p><p>يُستخدم دكستروز 5% وكلوريد الصوديوم 0.2%:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمصدر للكربوهيدرات (السكر).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لمعالجة نقص الجسم من المياه (الجفاف) والمواد الكيميائية (على سبيل المثال عن طريق التعرّق الشديد، واضطرابات الكلى)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لمعالجتك إذا كان حجم الدم في أوعيتك الدموية منخفضاً (نقص حجم الدم).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم دكستروز 5% وكلوريد الصوديوم 0.2% إذا كنت تعاني أيّاً من الحالات التالية</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما تعلم بأنّك تعاني حساسية من هذا المنتج</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل في المساحات التي تحيط بخلايا الجسم (فرط التعرّق خارج الخلية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يزيد حجم الدم في الأوعية الدموية عن المعدّل الطبيعي (فرط حجم الدم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود فائض من السوائل والصوديوم في الجسم (احتباس السوائل والصوديوم في الجسم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما تعاني مشاكل خطيرة في الكلى، فتشير إلى أنك تتبوّل أقلّ من المعتاد أو لا تتبوّل على الإطلاق (قلّة البول أو انقطاع البول)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم معاوضة فَشل القلب الغير معوض، أي فشل القلب الذي لم يتم علاجه بشكلٍ كافٍ ويسبّب الأعراض مثل:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الضيق في التنفس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورّم الكاحلين.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يكون مستوى الصوديوم في الدم أقلّ من المعدّل الطبيعي (نقص الصوديوم في الدم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يكون مستوى الكلوريد في الدم أقلّ من المعدّل الطبيعي (نقص الكلوريد في الدم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انتشار سائل تحت البشرة &nbsp;مؤثرا في جميع أنحاء الجسم (استسقاء عامّ)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التليف الكبدي الاستسقائي الذي يُسبّب احتباس السوائل في البطن( تليف الكبد)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مرض السكري الذي لا يُعالج بشكل ملائم، ممّا يؤدّي إلى ارتفاع مستويات السكر في الدم أكثر من المعدّل الطبيعي (مرض السكري غير المعوّض)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات أخرى من الحساسية ضدّ الدكستروز، على سبيل المثال:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إجهاد الأيض (عندما لا يعمل الأيض في الجسم بشكل صحيح بسبب مرض شديد مثلاً)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; غيبوبة فرط الأسمولية (فقدان الوعي). يعاني مرضى السكري هذا النوع من الغيبوبة حين لا يتلقّون كمية كافية من الأدوية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية عالية جداً من السكر في الدم (ارتفاع السكر في الدم بشكل ملحوظ)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يكون مستوى اللاكتات في الدم أعلى من المعدّل الطبيعي (زيادة اللاكتات في الدم)</p><p>تحذيرات واحتياطات</p><p dir="RTL">أعلم الطبيب إذا كنت تعاني أو عانيت مسبقاً هذه الحالات المرضية.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالات لها صلة باحتباس الصوديوم وزيادة السوائل والاستقساء، مثل</p><p dir="RTL"><em>- </em>الألدوستيرونية (مرض يسبّب مستويات عالية من هرمون يُسمّى الألدوستيرون) المرتبطة بـ</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في ضغط الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نوبة قلبية</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف وظائف الكبد أو التليف الكبدي الاستسقائي الذي يُسبّب احتباس السوائل في البطن (تليّف الكبد)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف في وظيفة الكليتين</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدم أثناء الحمل (مقدمات الارتعاج)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تناول بعض الأدوية، أنظر أدناه، فقرة &quot;أدوية أخرى مع دكستروز 5% وكلوريد الصوديوم 0.2%&quot;).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اضطراب يصبح فيه الدم قلوياً جداً (القلاء الأيضي)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضعف العضلات والشلل الدوري بسبب انخفاض نشاط الغدّة الدرقية (شلل التسمّم الدرقي الدوري)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان سريع للمياه من الجسم على سبيل المثال بسبب القيء أو الإسهال</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اعتماد نظام غذائي منخفض البوتاسيوم لفترة طويلة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية، تحديداً ضدّ الذرة (يحتوي دكستروز 5% وكلوريد الصوديوم 0.2% على سكر مشتقّ من الذرة)</p><p dir="RTL">قد يسبّب دكستروز</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات منخفضة من الصوديوم في الدم. قد يؤدي نقص الصوديوم في الدم إلى الصداع والغثيان والنوبات والخمول والغيبوبة والتورم في الدماغ والوفاة. يُعتبر اعتلال الدماغ الحاد بسبب نسبة الصوديوم مشكلة خطيرة. ثمّة بعض المرضى الذين يكونون عرضة بنسبة عالية لنقص الصوديوم في الدم. بشكل عام، ينطبق ذلك على</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشباب والمسنّين،</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النساء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وأي شخص يعاني حالة مثل انخفاض مستويات الأكسيجين في الدم (نقص الأكسجين)، وشرب الكثير من الماء بسبب جفاف الفم (العطاش نفسي المنشأ).</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشخص الذي خضع لجراحة مؤخراً.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيّرات في تركيزات المواد الكيميائية في الدم (اضطرابات في الشوارد الكهربائية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احتباس السوائل تحت البشرة، مما قد يؤثّر في جميع أجزاء الجسم (استقساء عامّ)، وتحديداً عند منطقة الكاحلين (استقساء محيطي) أو في الرئتين (استقساء رئوي)</p><p>عندما يتم إعطاؤك دكستروز، سيأخذ الطبيب عينات من دم وبول لمراقبة:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية المواد الكيميائية مثل الصوديوم والكلوريد في الدم (شوارد البلازما في دم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كمية السكر (الدكستروز)</p><p>بما أنّ دكستروز 5% وكلوريد الصوديوم 0.2% يحتويان على سكر (الدكستروز)، بإمكانهم أن يتسبّبا بارتفاع في مستوى السكر في الدم (ارتفاع السكر في الدم). وفي حال حدوث ذلك، قد يقوم الطبيب بـ:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تعديل سرعة إعطاء دكستروز</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إعطائك أنسولين لخفض مستويات السكر في الدم. وهذا أمر مهمّ بشكل خاصّ في حال:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني مرض السكري</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لم تكن تتناول الطعام بشكل صحيح أو تشرب المشروبات الروحية لفترة طويلة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرّضت مؤخراً لسكتة دماغية (سكتة دماغية حادّة). يمكن لمستويات السكر العالية في الدم أن تزيد من سوء آثار السكتة الدماغية وتؤثّر سلباً على التعافي</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا تعرّضت لإصابة في الرأس خلال الـ24 ساعة الماضية</p><p>سوف يأخذ الطبيب في الاعتبار إذا كنت تتلقى التغذية بالحقن (تغذية عن طريق الحقن في الوريد). قد تحتاج إلى تغذية إضافية عندما تتلقّى العلاج بدكستروز 5% وكلوريد الصوديوم 0.2% &nbsp;لفترة طويلة. كما يجب أن يراقب الطبيب مستوى البوتاسيوم في دمك لتجنّب انخفاضه دون المستوى الطبيعي (نقص البوتاسيوم في الدم).</p><p>الأطفال</p><p dir="RTL">ينبغي الانتباه جداً عند إعطاء هذا المحلول للأطفال والرضع وحديثي الولادة (تحديداً الأطفال الخدّج والأطفال ذوي الوزن دون الطبيعي عند الولادة). قد لا يتمكّن الأطفال والرضّع وحديثو الولادة من التعامل مع المواد الكيميائية التي يحتويها المحلول.</p><p>يُعدّ الأطفال الأصغر سناً أكثر عرضة لزيادة مستويات السكر في الدم التي قد تكون مرتفعة جداً أو منخفضة جداً، وبالتالي فهم بحاجة إلى مراقبة دقيقة أثناء العلاج لضمان التحكّم بمستويات السكر. كما يمكن أن يتسبّب انخفاض مستويات السكر لدى حديثي الولادة بنوبات طويلة، وغيبوبة وتلف في الدماغ. وقد ارتبطت مستويات السكر العالية بالنزيف في الدماغ، والعدوى البكتيرية والفطرية، والأضرار التي تلحق بالعين (اعتلال الشبكية لدى الأطفال الخدّج)، والالتهابات في الأمعاء، ومشاكل الرئة، وطول فترة الإقامة في المستشفى والوفاة.</p><p>يُعدّ الأطفال أكثر عرضة للمستويات المنخفضة من الصوديوم في الدم (نقص الصوديوم في الدم)، ما يؤدّي إلى صداع وغثيان ونوبات وخمول وغيبوبة وتورّم في الدماغ ووفاة. يُعتبر اعتلال الدماغ الحاد بسبب نسبة الصوديوم مشكلة خطيرة، تحديداً لدى الأطفال.</p><p dir="RTL">يعلم الطبيب بذلك وسيراقب بدقّة كمية المواد الكيميائية مثل الجلوكوز (السكر) والصوديوم والكلوريد في دم طفلك (شوارد البلازما)</p><p>تناول أدوية أخرى مع دكستروز 5% وكلوريد الصوديوم 0.2%</p><p dir="RTL">يجب إعلام الطبيب أو المُمرّضة إذا كنت تتناول أدوية أخرى، أو سبق أن تناولتها مؤخراً.</p><p dir="RTL">من المهم جداً أن تبلغ الطبيب إذا كنت تتناول:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كورتيكوستيرويد (أدوية مضّادة للالتهاب)</p><p dir="RTL">يمكن أن تتسبّب هذه الأدوية في احتباس الصوديوم والماء في الجسم، ممّا يؤدّي إلى:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورّم الأنسجة بسبب احتباس السوائل تحت البشرة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع في ضغط الدم.</p><p dir="RTL">أدوية أخرى يمكنها أن تؤثّر أو تتأثّر بدكستروز 5% وكلوريد الصوديوم 0.2%:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم (يُستخدم من أجل معالجة الأمراض النفسية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأنسولين (يُستخدم لعلاج مرض السكري)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص المياه (مدرّات البول)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حاصرات بيتا (أقراص القلب)</p><p>تلقّي دكستروز 5% وكلوريد الصوديوم 0.2% مع الأكل والشرب</p><p dir="RTL">يُفضّل أن تراجع الطبيب لمعرفة ما الذي يُسمح لك بتناوله أوشربه</p><p>الحمل والرضاعة الطبيعية والخصوبة</p><p dir="RTL">إذا كنتِ حاملاً أو ترضّعين طبيعياً، أو تعتقدين أنك حامل أو تخططين لتحملي، راجعي الطبيب أو المُمرّضة واطلبي نصيحتهما قبل أن تأخذي هذا الدواء.</p><p>يمكن استخدام دكستروز 5% وكلوريد الصوديوم 0.2% خلال الرضاعة.</p><p dir="RTL">ومع ذلك، إذا توجّب إضافة دواء آخر إلى المحلول الخاص بك للحقن أثناء الحمل أو الرضاعة الطبيعية، يجدر بك:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; استشارة الطبيب</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قراءة نشرة المريض للدواء المُضاف.</p><p>القيادة واستخدام الآلات</p><p dir="RTL">لا يؤثّر دكستروز 5% وكلوريد الصوديوم 0.2% في قدرتك على القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يعطيك الطبيب أو المُمرّضة دكستروز 5% وكلوريد الصوديوم 0.2%، وسيقرّر الطبيب النسبة التي تحتاج إليها والتوقيت المناسب. يعتمد هذا الأمر على العمر والوزن والحالة، وسبب استخدام دكستروز. كما قد تتأثّر الكمية التي تُعطى لك بالعلاجات التي تتلقاها.</p><p>يجب ألّا يتمّ وصف دكستروز 5% وكلوريد الصوديوم 0.2% لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال.</p><p><strong>&nbsp;</strong>يتمّ إعطاء دكستروز 5% ومحلول كلوريد الصوديوم 0.2% عبر أنبوب بلاستيكي موصول بإبرة يتم إدخالها في الوريد. عادة ما يُستخدم الوريد في ذراعك عند الحقن. ومع ذلك، قد يستخدم الطبيب طريقة أخرى ليعطيك الدواء.</p><p>يجب التخلّص من كل محلولٍ لم يتم استخدامه. لا يجب استخدام دكستروز 5% ومحلول كلوريد الصوديوم 0.45% من كيس سبق أن تمّ استخدامه جزئياً.</p><p>في حال تمّ حقن نسبة من دكستروز 5% وكلوريد الصوديوم 0.2% أعلى من المعدّل الطبيعي</p><p dir="RTL">في حال تمّ حقن نسبة من دكستروز 5% وكلوريد الصوديوم 0.2% فائضة عن المعدّل الطبيعي، أو تمّ حقن المحلول بسرعة، قد تظهر الأعراض التالية:</p><p>تشمل أعراض مستويات السكر العالية في الدم (ارتفاع السكر في الدم):</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; جفاف الفم بسبب نقص المياه في أنسجة الجسم (الجفاف)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العطش</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإرهاق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كثرة التبوّل بسبب زيادة إنتاج البول (إدرار البول التناضحي)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تشويش في البصر</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الإرهاق</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات منخفضة من الصوديوم في الدم (نقص الصوديوم في الدم)، ما يؤدي إلى صداع وغثيان ونوبات وخمول وغيبوبة وتورّم في الدماغ (استقساء دماغي) ووفاة.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يؤدّي تراكم السوائل في الجسم إلى تورّم (استقساء).</p><p>إذا تطوّرت لديك أي من هذه الأعراض يجب أن تقوم بإبلاغ الطبيب فوراً. سيتم إيقاف دكستروز ومنحك العلاج وفقاً للأعراض.</p><p dir="RTL">إذا أضيف دواء إلى دكستروز 5% وكلوريد الصوديوم 0.2% قبل حدوث الحقن الزائد، فإنّ هذا الدواء قد يسبب أعراضاً أيضاً. يجب أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفّر لائحة بالأعراض المُحتملة.</p><p>التوقّف عن تلقّي دكستروز 5% وكلوريد الصوديوم 0.2%</p><p><strong>&nbsp;</strong>يقرّر الطبيب وقت الانتهاء من أخذ دكستروز.</p><p>إذا كانت لديك أيّ أسئلة أخرى فلا تتردّد في استشارة الطبيب أو المُمرّضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد يسبّب دكستروز آثاراً جانبية مثل كافة الأدوية، مع العلم أنّها لا تظهر لدى جميع الأشخاص.</p><p>قد تتعلّق الآثار الجانبية ب دكستروز 5% وكلوريد الصوديوم 0.2% نفسها. ومن بين هذه الآثار الجانبية:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات فرط الحساسية، بما في ذلك حساسية خطيرة تُسمّى بالحساسية المفرطة (آثار تظهر لدى المرضى الذين يعانون حساسيّة ضدّ الذرة)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مستويات السكر العالية في الدم (ارتفاع السكر في الدم)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عندما يكون مستوى الصوديوم في الدم منخفضاً (نقص الصوديوم في الدم)</p><p>يمكن أن ترتبط الآثار الجانبية بتقنية الحقن. ومن بينها:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى (استجابة حموية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البرد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحُكاك أو الطفح الجلدي</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم موضعي أو ردّ فعل (ألم أو بثور في موقع الحقنة)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تهيّج والتهاب الوريد الذي تمّ حقن المحلول فيه (التهاب وريدي)، ممّا يسبب احمراراً، أو ألماً أو تورماً أو بثوراً على طول الوريد.</p><p>إذا تمت إضافة دواء إلى محلول الحقنة، قد يسبب الدواء المُضاف أيضاً آثاراً جانبية. تعتمد الآثار الجانبية هذه على الدواء الذي تمت إضافته. ينبغي أن تقرأ النشرة المرفقة بالدواء المُضاف حيث تتوفر قائمة بالأعراض المحتملة.</p><p><u>الإبلاغ عن آثار جانبية</u></p><p dir="RTL">أعلِم الطبيب أو المُمرّضة في حال عانيت آثاراً جانبية، حتى لو لم تكن مذكورة ضمن هذه النشرة. في حال ظهور أيّ من الأعراض، يجب التوقّف عن إعطاء دكستروز.</p><p dir="RTL">يمكنك أيضاً الإبلاغ عن الآثار الجانبية مباشرة (أنظر التفاصيل أدناه). من خلال الإبلاغ عن الآثار الجانبية، يمكنك أن تساعد على توفير مزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp; المملكة العربية السعودية:</p><table dir="rtl" cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top"><p dir="RTL">&nbsp;</p><p dir="RTL">- المركز الوطني للتيقظ والسلامة الدوائية</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فاكس: 7662-205-11-966+</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; للاتصال بالمركز الوطني للتيقظ والسلامة الدوائية: 2038222 11 966+، الأرقام الداخلية: 2317 - 2356 - 2353 - 2354 - 2334 - 2340.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الرقم المجاني: 8002490000</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الإلكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الموقع: www.sfda.gov.sa/npc</p><p dir="RTL">&nbsp;</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ هذا الدواء بعيداً عن متناول الأطفال.</p><p>يحفظ في درجةحرارة لا تزيد عن 30 درجة مئوية.</p><p>لا يجب وصف دكستروز 5% وكلوريد الصوديوم 0.2% بعد انتهاء تاريخ الصلاحية المطبوع على الكيس بعد كلمة EXP. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p>يجب ألّا يتمّ وصف دكستروز 5% وكلوريد الصوديوم 0.2% لكَ إذا كان هناك جسيمات عائمة في المحلول أو إذا كان الكيس تالفاً بأي شكلٍ من الأشكال.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>محتوى دكستروز 5% وكلوريد الصوديوم 0.2%</strong></p><p>المواد الفعّالة:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; السكر (الدكستروز): 50 غ في الليتر الواحد</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كلوريد الصوديوم: 2 في الليتر الواحد</p><p>المكونات الأخرى هي الماء المُخصّص للحقن، وحمض الهيدروكلوريك وهيدروكسيد الصوديوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>كيف يكون شكل محلول دكستروز 5% وكلوريد الصوديوم 0.2% ومحتويات الكيس</p><p><strong>&nbsp;</strong>تتألف أكياس Viaflex من البولي بلاستيك (كلوريد الفينيل) ويُغلّف كلّ كيس بغلافٍ خارجي من البلاستيك مختوم ومغلق</p><p>.-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حجم الكيس</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40 كيساً حجم 250 مل</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>26 كيساً حجم 500 مل</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>16 كيساً حجم 1000 مل</strong></p><p>لا يمكن تسويق جميع أحجام الأكياس.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الشركة الحائزة على ترخيص للتسويق والإنتاج</p><p><strong>&nbsp;</strong></p><p dir="RTL" style="margin-right:5.8pt; text-align:right">الشركة الحائزة على ترخيص للتسويق:</p><p>شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:320.2pt; margin-right:5.8pt; text-align:right">المنطقة الصناعية الثانية طريق رقم 2041 الدمام، المملكة العربية السعودية</p><p>&nbsp;</p><p dir="RTL" style="margin-right:5.8pt; text-align:right"><strong>الشركة المصنّعة:</strong></p><p>&nbsp;</p><p>شركة باكستر المحدودة</p><p dir="RTL" style="margin-left:320.2pt; margin-right:5.8pt; text-align:right">المنطقة الصناعية الثانية طريق رقم 2041 الدمام، المملكة العربية السعودية</p><p>تاريخ مراجعة معلومات هذه النشرة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
03/2016
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dextrose 5 % w/v& Sodium Chloride 0.2% w/v Solution for Intravenous Infusion in Viaflex.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dextrose (as monohydrate):          50.00 g/l (5.0 % w/v)
Sodium Chloride:                              2 g/l (0.2 % w/v)
Each ml contains 50 mg Dextrose (as monohydrate) and 2 mg Sodium chloride.
mmol/l:            Na+: 34         Cl-:34
mEq/l:              Na+: 34         Cl-:34
Nutritional value: Approximately 840 kJ/l (or 200 kcal/l)
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for infusion.
Clear solution, free from visible particles.
Osmolarity 346 mOsm/l (approx)
pH: 3.5 to 6.5
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dextrose 5 % w/vand Sodium Chloride 0.2% w/v solution is indicated for:<br />- Treatment of dehydration or hypovolaemia in cases where supply of water, sodium chloride and carbohydrates is required due to restriction of the<br />intake of fluids and electrolytes by normal routes.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The choice of the specific Sodium Chloride and Dextrose concentration, dosage, volume, rate and duration of administration depends on the age, weight, clinical<br />condition of the patient and concomitant therapy. It should be determined by a physician. For patients with electrolyte and dextrose abnormalities and<br />for paediatric patients, consult a physician experienced in intravenous fluid therapy. Rapid correction of hyponatraemia and hypernatraemia is potentially<br />dangerous (risk of serious neurologic complications).<br /><em><strong>Adults, older patients and adolescents (age 12 years and over):</strong></em><br />The Recommended dosage is 500 ml to 3 L/24h<br /><u>Administration rate</u><br />The infusion rate is usually 40 ml/kg/24h and should not exceed the patient&rsquo;s<br />Dextrose oxidation capacities in order to avoid hyperglycaemia. Therefore the maximum acute administration rate is 5 mg/kg/min.</p><p>Paediatric population<br />The dosage varies with weight:<br />0-10 kg body weight:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 100 ml/kg/24h<br />10-20 kg body weight:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1000 ml + (50 ml/kg over 10 kg)/24h<br />&gt; 20 kg body weight:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1500 ml + (20 ml/kg over 20 kg)/24h.<br />The administration rate varies with weight:<br />0-10 kg body weight:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6-8 ml/kg/h<br />10-20 kg body weight: &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 4-6 ml/kg/h<br />&gt; 20 kg body weight:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2-4 ml/kg/h<br />The infusion rate should not exceed the patient&rsquo;s dextrose oxidation capacities in order to avoid hyperglycaemia. Therefore the maximum acute administration<br />rate is 10-18 mg/kg/min, depending on the total body mass.<br />For all patients, a gradual increase of flow rate should be considered when starting administration of Dextrose containing products.<br /><u>Method of Administration</u><br />The administration is performed by intravenous infusion.<br />Dextrose 5.0 % w/v and Sodium Chloride 0.2 % w/v solution is hypotonic and hyperosmolar, due to the dextrose content. It has an approximate osmolarity of 346 mOsm/l</p><p><em>Precautions to be taken before<u> manipulating </u>or administering the product</em><br />Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration.</p><p>Do not administer unless the solution is clear and the seal is intact. Administer immediately following the insertion of<br />infusion set. Do not remove unit from overwrap until ready for use. The inner bag maintains the sterility of the product.<br />The solution should be administered with sterile equipment using an aseptic technique. The equipment should be primed with the solution in order to<br />prevent air entering the system.<br />Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before<br />the administration of the fluid from the secondary container is completed.<br />Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in air embolism if the residual air in the<br />container is not fully evacuated prior to administration.<br />Use of a vented intravenous administration set with the vent in the open position could result in air embolism. Vented intravenous administration sets<br />with the vent in the open position should not be used with flexible plastic containers.<br />Additives may be introduced before or during infusion through the resealable medication port. When additive is used, verify tonicity prior to parenteral<br />administration. Hyperosmolar solutions may cause venous irritation and phlebitis. Thus, any hyperosmolar solution is recommended to be administered<br />through a large central vein, for rapid dilution of the hyperosmotic solution.<br />For further information on the product with additives, please see sections 6.2, 6.3 and 6.6.<br /><u>Monitoring</u><br />Fluid balance and the concentrations of dextrose and electrolytes (especially sodium) in plasma must be monitored during administration. Electrolyte<br />supplementation may be indicated according to the clinical needs of the patient.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                The solution is contraindicated in patients presenting with:
• Known hypersensitivity to the product
• Extracellular hyperhydration or hypervolaemia
• Fluid and sodium retention
• Severe renal insufficiency (with oliguria/anuria)
• Uncompensated cardiac failure
• Hyponatraemia or hypochloraemia
• General oedema and ascitic cirrhosis
• Clinically significant hyperglycaemia.
The solution is also contraindicated in case of uncompensated diabetes,
other known dextrose intolerances (such as metabolic stress situations),
hyperosmolar coma or hyperlactataemia.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Hyponatraemia</em><br />The infusion of solutions with sodium concentrations &lt;0.9% may result in hyponatraemia. Close clinical monitoring may be warranted.<br />Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral oedema, and death. Acute symptomatic hyponatraemic<br />encephalopathy is considered a medical emergency.<br />The risk for hyponatraemia is increased, for example,<br />&bull; in children<br />&bull; in older patients<br />&bull; in women<br />&bull; postoperatively<br />&bull; in persons with psychogenic polydipsia<br />&bull; in patients treated with medications that increase the risk of<br />hyponatraemia (such as certain antiepileptic and psychotropic medications).</p><p>The risk for developing hyponatraemic encephalopathy is increased, for example,<br />&bull; In paediatric patients (&le;16 years of age)<br />&bull; in women (in particular, premenopausal women)<br />&bull; in patients with hypoxaemia<br />&bull; in patients with underlying central nervous system disease.<br />Sodium retention, fluid overload and oedema<br />Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v solution should be used with particular caution, in:<br />&bull; Patients with conditions that may cause sodium retention, fluid overload and oedema (central and peripheral), such as<br />○ Primary hyperaldosteronism,<br />○ Secondary hyperaldosteronism associated with, for example,<br />■ hypertension,<br />■ congestive heart failure,<br />■ liver disease (including cirrhosis),<br />■ renal disease (including renal artery stenosis, nephrosclerosis)<br />○ Pre-eclampsia.<br />&bull; Patients taking medications that may increase the risk of sodium and fluid retention, such as corticosteroids<br /><em>Hypokalaemia</em><br />The infusion of Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v solution may result in hypokalaemia. This medicine should be used with particular caution<br />in patients with or at risk for hypokalemia. Close clinical monitoring may be warranted in, for example:<br />&bull; persons with metabolic alkalosis<br />&bull; persons with thyrotoxic periodic paralysis, administration of intravenous dextrose has been associated in aggravating hypokalaemia<br />&bull; persons with increased gastrointestinal losses (e.g., diarrhea, vomiting)<br />&bull; prolonged low potassium diet</p><p>&bull; persons with primary hyperaldosteronism<br />&bull; patients treated with medications that increase the risk of hypokalaemia (e.g. diuretics, beta-2 agonist, or insulin).<br />Hypo- and hyperosmolality, serum electrolytes and water imbalance<br />Depending on the volume and rate of infusion and depending on a patient&rsquo;s underlying clinical condition and capability to metabolize dextrose, intravenous<br />administration of Dextrose 5% w/v and Sodium Chloride 0.2 % w/v solution can cause:<br />&bull; Hypo-osmolality<br />&bull; Hyperosmolality, osmotic diuresis and dehydration<br />&bull; Electrolyte disturbances such as<br />○○ hyponatraemia (see above),<br />○○ hypokalaemia (see above),<br />○○ hypophosphataemia,<br />○○ hypomagnesaemia,<br />&bull; Overhydration/hypervolaemia and, for example, congested states, including central (e.g., pulmonary congestion) and peripheral oedema.<br />Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations and acid-base<br />balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.<br /><em>Hyperglycaemia</em><br />Rapid administration of Dextrose solutions may produce substantial hyperglycaemia and a hyperosmolar syndrome. In order to avoid<br />hyperglycaemia the infusion rate should not exceed the patient&rsquo;s ability to utilize glu Dextrose cose.<br />To reduce the risk of hyperglycaemia-associated complications, the infusion rate must be adjusted and/or insulin administered if blood dextrose levels<br />exceed levels considered acceptable for the individual patient.<br />Intravenous Dextrose should be administered with caution in patients with, for example:</p><p>&bull; impaired dextrose tolerance (such as in diabetes mellitus, renal impairment, or in the presence of sepsis, trauma or shock),<br />&bull; severe malnutrition (risk of precipitating a refeeding syndrome, see below), thiamine deficiency, e.g., in patients with chronic alcoholism<br />&nbsp; (risk of severe lactic acidosis due to impaired oxidative metabolism of pyruvate),<br />&bull; water and electrolyte disturbances that could be aggravated by increased dextrose and/or free water load<br />&nbsp; Other groups of patients in whom Dextrose 5% w/v and Sodium Chloride 0.2 % w/v solution should be used with caution include:<br />&bull; Patients with ischemic stroke. hyperglycaemia has been implicated in increasing cerebral ischemic brain damage and impairing recovery after acute ischemic strokes.</p><p>&bull; Patients with severe traumatic brain injury (in particular during the first 24 hours following the trauma). Early hyperglycaemia has been<br />&nbsp;&nbsp; associated with poor outcomes in patients with severe traumatic brain injury.<br />&bull; Newborns (see Paediatric glycaemia-related issues).<br />Prolonged intravenous administration of dextrose and associated hyperglycaemia may result in decreased rates of dextrose -stimulated insulin secretion.<br /><em>Hypersensitivity Reactions</em><br />&bull; Hypersensitivity/infusion reactions, including anaphylaxis, have been reported (see section 4.8).<br />&bull; Stop the infusion immediately if signs or symptoms of hypersensitivity/infusion reactions develop. Appropriate therapeutic countermeasures must be instituted as clinically indicated.<br />Solutions containing dextrose should be used with caution in patients with known allergy to corn or corn products<br /><em>Refeeding syndrome</em><br />Refeeding severely undernourished patients may result in the refeeding syndrome that is characterized by the shift of potassium, phosphorus and<br />magnesium intracellularly as the patient becomes anabolic. Thiamine deficiency and fluid retention may also develop. Careful monitoring and slowly<br />increasing nutrient intake while avoiding overfeeding can prevent these complications.<br /><em>Severe renal impairment</em><br />Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v solution should be administered with particular caution to patients at risk of (severe) renal<br />impairment. In such patients, administration may result in sodium retention and/or fluid overload.<br /><em>Paediatric use</em></p><p>The infusion rate and volume depends on the age, weight, clinical and metabolic conditions of the patient, concomitant therapy, and should be<br />determined by a physician experienced in paediatric intravenous fluid therapy.<br /><em><u>Paediatric glycaemia-related issues</u></em><br />&bull; Newborns, especially those born premature and with low birth weight, are at increased risk of developing hypo- or hyperglycaemia. Close<br />monitoring during treatment with intravenous dextrose solutions is needed to ensure adequate glycaemic control, in order to avoid potential long term adverse effects.<br />&bull; Hypoglycaemia in the newborn can cause, e.g.,<br />&nbsp;&nbsp; ○ prolonged seizures,<br />&nbsp;&nbsp; ○ coma and<br />&nbsp;&nbsp; ○ cerebral injury.<br />&bull; Hyperglycaemia has been associated with<br />&nbsp;&nbsp;&nbsp; ○ cerebral injury, including intraventricular haemorrhage,<br />&nbsp;&nbsp;&nbsp; ○ late onset bacterial and fungal infection,<br />&nbsp;&nbsp;&nbsp; ○ retinopathy of prematurity,<br />&nbsp;&nbsp;&nbsp; ○ necrotizing enterocolitis,<br />&nbsp;&nbsp;&nbsp; ○ increased oxygen requirements,<br />&nbsp;&nbsp;&nbsp; ○ prolonged length of hospital stay and<br />&nbsp;&nbsp;&nbsp; ○ death.<br />Paediatric hyponatraemia-related issues<br />&bull; Children (including neonates and older children) are at increased risk of developing hyponatraemia as well as for developing hyponatraemic encephalopathy.<br />&nbsp;&nbsp; The infusion of hypotonic fluids together with the non-osmotic secretion of ADH may result in hyponatraemia.<br />&bull; Hyponatraemia can lead to headache, nausea, seizures, lethargy, coma, cerebral edema and death; therefore, acute symptomatic hyponatraemic encephalopathy is considered a medical emergency.<br />&bull; Plasma electrolyte concentrations should be closely monitored in the paediatric population.</p><p>&bull; Rapid correction of hyponatraemia is potentially dangerous (risk of serious neurologic complications). Dosage, rate, and duration of &nbsp; administration should be determined by a physician experienced in<br />&nbsp; paediatric intravenous fluid therapy.<br /><em>Blood</em><br />Sodium Chloride 0.2 % w/v and Dextrose 5.0 % w/v solution should not be<br />administered simultaneously with blood through the same administration set<br />because of the possibility of pseudoagglutination or haemolysis.<br /><em>Geriatric use</em><br />When selecting the type of infusion and the volume/rate of infusion for a geriatric patient, consider that geriatric patients are generally more likely tohave cardiac, renal, hepatic, and other diseases or concomitant drug therapy.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies have been conducted by Baxter. Both the glycaemic and effects on<br />water and electrolyte balance should be taken into account when administering<br />Dextrose 5.0 % w/v and Sodium Chloride 0.2 % w/v solution to patients treated<br />with other substances that affect glycaemic control or fluid and/or electrolyte balance.<br />Caution is advised in patients treated with<br />&bull; lithium. Renal sodium and lithium clearance may be increased during administration and can result in decreased lithium levels.<br />&bull; corticosteroids, which are associated with the retention of sodium and water (with oedema and hypertension).<br />&bull; diuretics, beta-2 agonist, or insulin, whom increase the risk of hypokalemia<br />&bull; certain antiepileptic and psychotropic medications that increase the risk of hyponatraemia.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><em>Pregnancy</em></strong><br />Intrapartum maternal intravenous dextrose infusion may result in foetal<br />hyperglycaemia and metabolic acidosis as well as rebound neonatal<br />hypoglycaemia due to foetal insulin production.<br /><strong><em>Fertility</em></strong><br />There is no information on the effects of solution on fertility.<br /><strong><em>Lactation</em></strong><br />Dextrose 5.0% and Sodium Chloride 0.2% solution can be used during breastfeeding.<br />The potential risks and benefits for each specific patient should be<br />carefully considered before administration.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There is no information on the effects of Dextrose 5.0% and Sodium Chloride<br />0.2% solution on the ability to operate an automobile or other heavy machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following adverse reactions have been reported reported in post-marketing experience, listed by MedDRA System Organ Class (SOC), then where feasible, by<br />Preferred Term in order of severity.<br />Frequencies cannot be estimated from the available data as all listed adverse reactions are based on spontaneous reporting</p><p>&nbsp;</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:233.75pt"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top; width:233.75pt"><p><strong>Adverse reactions (Preferred terms)</strong></p></td></tr><tr><td rowspan="3" style="vertical-align:top; width:233.75pt"><p>Metabolism and nutrition disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Hypervolaemia</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Electrolyte imbalance</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Hyponatraemia*</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Cardiac disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Cardiac failure</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Renal and urinary disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Polyuria</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:233.75pt"><p>Immune system disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Hypersensitivity</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Anaphylactic reaction</p></td></tr></tbody></table><p style="text-align:center">*Potential manifestation in patients with allergy to corn, see section 4.4</p><p><em>Adverse reactions </em>may be <em>associated </em>to the medicinal product(s) added to the solution;</p><p style="text-align:center">the nature of <em>the </em>additive will determine the likelihood <em>of </em>any other adverse reactions.</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:233.75pt"><p><strong>System Organ Class </strong></p></td><td style="vertical-align:top; width:233.75pt"><p><strong>Adverse reactions (Preferred Terms)</strong></p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p style="text-align:center">Metabolism and nutrition disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Hypervolaemia</p></td></tr><tr><td rowspan="2" style="vertical-align:top; width:233.75pt"><p>Vascular disorders</p></td><td style="vertical-align:top; width:233.75pt"><p>Vein injury</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Thrombophlebitis superficial</p></td></tr><tr><td rowspan="7" style="vertical-align:top; width:233.75pt"><p>General disorders and administration site</p><p>conditions</p></td><td style="vertical-align:top; width:233.75pt"><p>Chills</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Pyrexia</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Application site infection</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Application site pain</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Application site reaction</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Injection site phlebitis</p></td></tr><tr><td style="vertical-align:top; width:233.75pt"><p>Injection site extravasation</p></td></tr></tbody></table><p><u>Reporting of suspected adverse reactions</u></p><p>&bull; Reporting suspected adverse reactions after authorisation of the medicinal product</p><p>is important. It allows continued monitoring of the benefit/risk balance of the</p><p>medicinal product. Healthcare professionals are asked to report any suspected</p><p>adverse reactions via</p><table cellspacing="0" cellpadding="0" border="1"><tbody><tr><td style="vertical-align:top; width:467.5pt"><p>&bull; Saudi Arabia:</p><p>- The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>&bull; Fax: +966-11-205-7662</p><p>&bull; Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>&bull; Toll free phone: 8002490000</p><p>&bull; E-mail: npc.drug@sfda.gov.sa</p><p>&bull; Website: www.sfda.gov.sa/npc</p><p>&bull; Other GCC States:</p><p>- Please contact the relevant competent authority.</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Excess administration of Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v solution can cause:<br />&bull; Hyperglycaemia, adverse effects on water and electrolyte balance, and<br />corresponding complications. For example, severe hyperglycaemia and<br />severe dilutional hyponatraemia, and their complications, can be fatal.<br />&bull; Hyponatraemia (which can lead to CNS manifestations, including seizures, coma, cerebral oedema and death).<br />&bull; Fluid overload (which can lead to central and/or peripheral oedema).<br />&bull; See also sections 4.4 and 4.8.<br />When assessing an overdose, any additives in the solution must also be considered. Clinically significant overdose of Dextrose 5 % w/v and Sodium<br />Chloride 0.2 % w/v solution may therefore, constitute a medical emergency. Interventions include discontinuation of administration, dose reduction,<br />administration of insulin and other measures as indicated for the specific clinical constellation.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group &ldquo;Electrolytes with Carbohydrates&rdquo;, ATC code:<br />&ldquo;B05BB02&rdquo;. Dextrose 5 % and Sodium Chloride 0.2 % is a hypotonic and<br />hyperosmolar solution of sodium chloride and dextrose.<br />The pharmacodynamic properties of Dextrose 5 % w/v and Sodium Chloride<br />0.2 % w/v solution are those of its components (sodium chloride and dextrose).<br />Ions, such as sodium, circulate through the cell membrane, using various<br />mechanisms of transport, among which is the sodium pump<br />(Na+/K+-ATPase). Sodium plays an important role in neurotransmission and<br />cardiac electrophysiology, and also in its renal metabolisem.<br />Chloride is mainly an extracellular anion. Intracellular chloride is in high<br />concentration in red blood cells and gastric mucosa. Re-absorption of chloride<br />follows re-absorption of sodium.<br />Dextrose is the principal source of energy in cellular metabolism. The Dextrose<br />in this solution provides a caloric intake of 200kcal/l.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The pharmacokinetic properties of this solution are those of its components (sodium, chloride and dextrose).<br />After injection of radiosodium (24Na), the half -life is 11 to 13 days for 99%<br />of the injected Na and one year for the remaining 1%. The distribution varies<br />according to tissues: it is fast in muscles, liver, kidney, cartilage and skin;<br />it is slow in erythrocytes and neurones; it is very slow in the bone. Sodium<br />is predominantly excreted by the kidneys, but (as described earlier) there is<br />extensive renal re-absorption. Small amounts of sodium are lost in the faeces<br />and sweat.<br />The two main metabolic pathways of dextrose are gluconeogenesis (energy storage) and glycogenolysis (energy release). Dextrose metabolism is regulated<br />by insulin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical safety data of this solution for infusion in animals are not relevant<br />since its constituents are physiological components of animal and human plasma.<br />Toxic effects are not to be expected under the condition of clinical application.<br />The safety of potential additives should be considered separately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Water for Injections<br />Sodium chloride</p><p>Hydrochloric acid</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Incompatibility of the medicinal product to be added with the solution in the<br />Viaflex container must be assessed before addition.<br />In the absence of compatibility studies, this solution must not be mixed with<br />other medicinal products.<br />The Instructions for Use of the medicinal product to be added must be<br />consulted. Before adding a drug, verify it is soluble and stable in water at the<br />pH of Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v solution (see section 3).<br />As guidance, the following medications are incompatible with the Dextrose 5 %<br />w/v and Sodium Chloride 0.2 % w/v solution (non-exhaustive listing):<br />- Ampicillin sodium<br />- Mitomycin<br />- Erythromycin lactobionate<br />- Human insulin<br />Those additives known to be incompatible should not be used.<br />Because of the presence of Dextrose 5 % w/v and Sodium Chloride 0.2 % w/v<br />solution should not be administered simultaneously with blood through the<br />same administration set because of the possibility of pseudoagglutination or<br />haemolysis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Shelf life as packaged:
250 ml bag: 18 months
500 ml bag 24 months
1000 ml bags: 24 months
In-use shelf life: Additives:
From a physico-chemical viewpoint, solution containing additives should
be used immediately unless chemical and physical in-use stability has
been established.
From a microbiological point of view, solutions containing additives should
be used immediately. If not used immediately, in-use storage times
and conditions prior to use are the responsibility of the user and would
normally not be longer than 24 hours at 2 to 8°C, unless reconstitution
has taken place in controlled and validated aseptic conditions
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The bags known as VIAFLEX are composed of poly(vinyl chloride) plastic<br />bag are (VIAFLEX). Each bag is wrapped in a sealed, protective, outer plastic<br />overpouch.<br />.<br />- The bag size are:<br />-- 40 bags of 250 ml<br />-- 26 bags of 500 ml<br />- 16 bags of 1000 ml<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Discard after single use.<br />Discard any unused portion.<br />Do not reconnect partially used bags.</p><p>For method of administration and precautions to be taken before handling or administering the medicinal product, please see also section 4.2.<br />1. &nbsp;&nbsp; Opening<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a. Remove the Viaflex container from the overpouch just before use.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution, as sterility may be impaired.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c. Check the solution for limpidity and absence of foreign matters. If solution is not clear or contains foreign matters, discard the solution.<br />2. Preparation for administration<br />Use sterile material for preparation and administration.</p><p>a. Suspend container from eyelet support.<br />b. Remove plastic protector from outlet port at bottom of container:<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - grip the small wing on the neck of the port with one hand<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - grip the large wing on the cap with the other hand and twist<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - the cap will pop off.<br />c. Use an aseptic method to set up the infusion<br />d. Attach administration set. Refer to complete directions accompanying set<br />for connection, priming of the set and administration of the solution.<br />3. Techniques for injection of additive medications</p><p><br />Warning: Additives may be incompatible.<br />To add medication before administration<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a. Disinfect medication site.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c. Mix solution and medication thoroughly. For high-density medication such as potassium chloride, tap the ports gently while ports are upright and mix.</p><p><em>Caution: Do not store bags containing added medications. See section 6.3.</em><br />To add medicationduring administration<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; a. Close clamp on the set.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; b. Disinfect medication site.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; c. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; d. Remove container from IV pole and/or turn to an upright position.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; e. Evacuate both ports by tapping gently while the container is in an upright position.<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; f. Mix solution and medication thoroughly.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; g. Return container to in use position, re-open the clamp and continue administration.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Baxter Company Limited
2nd Industrial Zone Road no 2041
Dammam, Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                03/2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>